BS, Brigham Young University-Idaho (2003-2006)
MS, Brigham Young University (2006-2008)
PhD, Duke University (2010-2014)
Postdoctoral Fellow, Huntsman Cancer Institute
Assistant Professor, Idaho State University
Dr. Barrott is trained in cancer pharmacology with a background in genetics. He uses an interdisciplinary approach to design and test novel personalized approaches for treating rare bone and muscle cancers called sarcomas. Novel anticancer therapies can be tested in a variety of cancer models found in the Barrott lab including cancer cell lines, 3D tumor organoids, and genetically engineered mouse models. Using the genetic profiles of cancers, Dr. Barrott can understand the unique features of these cancers that differentiate themselves from normal tissue and exposing a vulnerability where targeted therapies can work.
Publications: https://www.ncbi.nlm.nih.gov/myncbi/jared.barrott.1/bibliography/public/